← Back to Search

Personalized Smartwatch for Cancer

N/A
Waitlist Available
Led By Zan Gao
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial seeks to test the efficacy of a self-regulation based physical activity intervention in promoting PA and improving health outcomes in a sample of low-income, ethnically diverse, older CS.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Daily Calories Burned
Change in Daily Steps
Secondary outcome measures
Change in Body Mass Index (BMI)
Change in Patient-Reported Outcome Measurement Information System Score
Change in Physical Activity Confidence Scale Score
+2 more
Other outcome measures
Change in Sentiments

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Smartwatch ConditionExperimental Treatment1 Intervention
Participants assigned to this intervention will use a Fitbit to track daily physical activity (PA), share PA data remotely, and receive personalized feedback.
Group II: Facebook ConditionExperimental Treatment1 Intervention
Participants assigned to this intervention will take part in personalized Facebook health education, receive a smartwatch, receive weekly health education, share sentiments on Facebook, and receive personalized feedback.
Group III: Combined ConditionExperimental Treatment2 Interventions
Participants assigned to this condition will receive both Fitbit and Facebook health education programs, (The Smartwatch and Facebook Conditions). The investigators will also provide weekly personalized feedback, based on PA data and sentiment analysis, that have been developed in prior pilot studies.
Group IV: Attention ControlActive Control1 Intervention
Participants assigned to the control condition will not receive any intervention. They will receive a Fitbit smartwatch, and continue with their standard care currently done in their life during the intervention period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Personalized Smartwatch
2021
N/A
~130
Facebook Health Education
2021
N/A
~130

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,649 Total Patients Enrolled
Zan GaoPrincipal InvestigatorUniversity of Minnesota School of Kinesiology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~37 spots leftby Apr 2025